New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
06:05 EDTJAZZJazz Pharmaceuticals price target raised to $195 from $132 at Citigroup
Citigroup raised its price target for Jazz Pharmaceuticals shares to $195 following the company's Q4 results and keeps a Buy rating on the stock. Citi says the CFO departure likely eases some of the takeout speculation around the stock, but it points out Jazz's 2014 guidance points to solid top and bottom line growth.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
07:54 EDTJAZZJazz Pharmaceuticals management to meet with UBS
Subscribe for More Information
September 24, 2014
07:55 EDTJAZZJazz Pharmaceuticals management to meet with UBS
Meetings to be held in Geneva/Zurich on September 24 hosted by UBS.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use